Chinese Biotech Firm Burning Rock Snags $125.5 million

Burning Rock, a Chinese biotech firm, has raised 850 million Yuan (over $125.5 million) in Series C round led by Singapore’s sovereign wealth fund GIC. Other investors include LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital.

Burning Rock’s 3 core businesses include cancer patient companion diagnostics, early cancer detection, and cancer genome big data ecosystem.

Earlier in 2016, Burning Rock also raised 300 million Yuan in Series A round led by Sequoia, LYFE Capital, CMB International Capital and Legend Star.

Elvis Gomes